Melasma ve D Vitamini
Özet
Melasma, genellikle güneşe maruz kalan yüz bölgelerinde gri-kahverengi lekelerle beliren, kronik ve edinsel bir pigmentasyon hastalığıdır. Genetik yatkınlık, güneş ışınları, gebelik ve koyu cilt tipi gibi faktörler melasma gelişiminde etkilidir. Tedavi ve korunmada sıkı bir güneş koruması esas olduğundan, bu durum deride D vitamini sentezini sınırlayabilmektedir. Yapılan klinik çalışmalar, melasma hastalarında —özellikle kadınlarda— D vitamini seviyelerinin sağlıklı kontrollere göre anlamlı derecede düşük olduğunu ve bu eksikliğin periodontit gibi durumlarla da ilişkili olabileceğini göstermektedir. Melaninin ultraviyole (UVB) ışınlarını emerek D vitamini sentezini yavaşlatması nedeniyle, koyu cilt tipine sahip bireyler hipovitaminoz riski altındadır. D vitamininin melanositler üzerindeki etkilerine dair araştırmalar çelişkili olmakla birlikte, genellikle melanin üretimini ve melanosit sağlığını koordine ettiği yönündedir. Günlük güneş koruyucu kullanımının D vitamini sentezini gerçek yaşam koşullarında engellediğine dair kesin bir klinik veri olmasa da melasma hastalarında tedavi başlangıcında bazal D vitamini ölçümü yapılması, yeterli alıma dikkat edilmesi ve oral D vitamini replasmanı yapılması önerilmektedir.
Melasma is a chronic, acquired pigmentation disorder characterized by grayish-brown patches primarily appearing on sun-exposed facial areas. Factors such as genetic predisposition, sun exposure, pregnancy, and dark skin types play significant roles in its development. Since rigorous sun protection is fundamental in melasma management and prevention, it can potentially restrict cutaneous vitamin D synthesis. Clinical studies demonstrate that vitamin D levels in melasma patients—particularly in women—are significantly lower compared to healthy controls, and this deficiency may also correlate with conditions like periodontitis. Because melanin absorbs UVB radiation and slows down vitamin D production, individuals with darker skin phenotypes are inherently predisposed to hypovitaminosis. Although research regarding the effects of vitamin D on melanocytes remains controversial, it generally indicates that the vitamin coordinates melanin production and supports melanocyte viability. While robust clinical data showing that daily sunscreen application inhibits real-life vitamin D synthesis is lacking, evaluating baseline vitamin D levels at the initiation of melasma treatment, ensuring adequate daily intake, and implementing oral vitamin D replacement are highly recommended.
Referanslar
Oluwatobi A., Ogbechie-Godec, Elbuluk N. Melasma: an Up-to-Date Comprehensive Review. Dermatol & Therapy J. 2017; 7(3): 305-18.
Dessinioti C, Lotti TM, Stratigos AJ, et al. Melasma. In Katsambas AD, Lotti TM, Dessinioti C, D'erme AM (Eds.), Europen Handbook Dermatological Treatments. Springer-Verlag, Berlin Heidelberg. 2015: 613-9.
Rodrigues M, Pandya AP. Melasma: clinical diagnosis and management options. Austral J Dermatol. 2015; 56: 151-63.
Küçük ÖS. Current Treatment Approaches for Melasma. Bezmialem Science. 2018; 6: 54-62.
Abdalla MA, Nayaf MS, Hussein SZ. Evaluation of Vitamin D in Melasma Patients. Revista Română de Medicină de Laborator. 2019 ;27(2): 219-221.
Chaitanya NC, Priyanka DR, Madireddy N, et al. Melasma Associated with Periodontitis, Anemia, and Vitamin D Abnormalities: A Chance Occurrence or a Syndrome. J Contemp Dent Pract. 2018;19(10):1254-1259.
AlGhamdi K, Kumar A, Moussa N. The role of vitamin D in melanogenesis with an emphasis on vitiligo. Indian J Dermatol Venereol Leprol. 2013;79:750-8.
Parsad D, Saini R, Verma N. Combination of PUVAsol and topical calcipotriol in vitiligo. Dermatology. 1998;197:167-70.
Parsad D, Kanwar AJ. Topical vitamin D3 analogues in the treatment of vitiligo. Pigment Cell Melanoma Res. 2009;22:487-8.
Baysal V, Yildirim M, Erel A, Kesici D. Is the combination of calcipotriol and PUVA effective in vitiligo? J Eur Acad Dermatol Venereol. 2003;17:299-302.
Yalçın B, Sahin S, Bükülmez G, et al. Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA alone: A preliminary study. J Am Acad Dermatol. 2001;44:634-7.
Milde P, Hauser U, Simon T, et al. Expression of 1,25-dihydroxyvitamin D3 receptors in normal and psoriatic skin. J Invest Dermatol. 1991;97(2):230-239.
Oikawa A, Nakayasu M. Stimulation of melanogenesis in cultured melanoma cells by calciferols. FEBS Lett. 1974;42:32-5.
Ranson M, Posen S, Mason RS. Human melanocytes as a target tissue for hormones: in vitro studies with 1 alpha-25, dihydroxyvitamin D3, alphamelanocyte stimulating hormone, and beta-estradiol. J Invest Dermatol. 1988;91(6):593-8.
Kuroki T. Possible functions of 1 alpha,25-dihydroxyvitamin D3, an active form of vitamin D3, in the differentiation and development of skin. J Invest Dermatol. 1985;84(6):459-60.
Tomita Y, Torinuki W, Tagami H. Stimulation of human melanocytes by vitamin D3 possibly mediates skin pigmentation after sun exposure. J Invest Dermatol. 1988;90:882-4.
Watabe H, Soma Y, Kawa Y, et al. Differentiation of murine melanocyte precursors induced by 1,25-dihydroxyvitamin D3 is associated with the stimulation of endothelin B receptor expression. J Invest Dermatol. 2002;119:583-9.
Mansur CP, Gordon PR, Ray S, et al. Vitamin D, its precursors, and metabolites do not affect melanization of cultured human melanocytes. J Invest Dermatol. 1988;91(1):16-21.
Birlea SA, Costin GE, Norri DA. New insights on therapy with Vitamin D analogs targeting the intracellular pathways that control repigmentation in human vitiligo. Med Res Rev. 2009;29:514-46.
Hong DK, Kim TJY, Park JK, Haw CR. Effect of calcipotriol (MC 903), a novel synthetic derivative of vitamin D on the growth of cultured human keratinocytes and melanocytes. Korean J Dermatol. 1992;30:811-23.
Abdel-Malek ZA, Ross R, Trinkle L, et al. Hormonal effects of vitamin D3 on epidermal melanocytes. J Cell Physiol. 1988;136:273-80.
Tadokoro T, Yamaguchi Y, Batzer J, et al. Mechanisms of skin tanning in different racial/ethnic groups in response to ultraviolet radiation. J Invest Dermatol. 2005;124:1326-32.
Birlea SA, Costin GE, Norris DA. Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation. Curr Drug Targets. 2008;9:345-59.
De Haes P, Garmyn M, Degreef H, et al. 1,25-Dihydroxyvitamin D3 inhibits ultraviolet B-induced apoptosis, Jun kinase activation, and interleukin-6 production in primary human keratinocytes. J Cell Biochem. 2003;89:663-73.
Mason RS, Holliday CJ. 1,25-Dihydroxyvitamin D Contributes to Photoprotection in Skin Cells. In: Norman A, Bouillon R, Thomasset M (Eds.), Vitamin D Endocrine System: Structural, Biological, Genetic and Clinical Aspects. Riverside: University of California. 2000:605-8.
Sauer B, Ruwisch L, Kleuser B. Antiapoptotic action of 1alpha, 25-dihydroxyvitamin D3 in primary human melanocytes. Melanoma Res. 2003;13:339-4770.
Han J, Colditz GA, Hunter DJ. Polymorphisms in the MTHFR and VDR genes and skin cancer risk. Carcinogenesis. 2007;28:390-7.
Jablonski NG. The evolution of human skin and skin color. Annu Rev Anthropol. 2004;33:585-623.
Loomis WF. Skin-pigment regulation of vitamin-D biosynthesis in man. Science. 1967;157:501-6.
Becker S, Schiekofer C, Vogt T, Reichrath J. Melasma Ein Update zu Klinik, Therapie und Prävention. Hautarzt. 2017; 68: 120-6.
Lips P. Worldwide status of vitamin D nutrition. J Steroid Biochem Mol Biol. 2010;121(1):297-300.
Felton SJ. Concurrent beneficial (vitamin D production) and hazardous (cutaneous DNA damage) impact of low-level summer sunlight exposures. Br J Dermatol. 2016;175(6):1320–8.
Kalajian TA, Aldoukhi A, Veronikis AJ, et al. Ultraviolet B light emitting diodes (LEDs) are more efficient and effective in producing Vitamin D3 in human skin compared to natural sunlight. Sci Reports. 2017; 7 (1):1-8.
Gozdzik A, Barta JL, Weir A, et al. Serum 25-hydroxyvitamin D concentrations fluctuate seasonally in young adults of diverse ancestry living in Toronto. J Nutr. 2010;140(12):2213–20.
Holick MF. Biological effects of sunlight, ultraviolet radiation, visible light, infrared radiation and vitamin D for health. Anticancer Res. 2016;36:1345–56.
Holick MF. McCollum award lecture 1994: Vitamin D: New horizons for the 21st century. Am J Clin Nutr. 1994;60:619-30.
Willis CM, Laing EM, Hall DB, et al. A prospective analysis of plasma 25-hydroxyvitamin D concentrations in white and black prepubertal females in the southeastern United States. Am J Clin Nutr. 2007;85:124-30.
Prabhu AV, Luu W, Li D, et al. DHCR7: A vital enzyme switch between cholesterol and vitamin D productionProg. Lipid Res. 2016; 64: 138-51.
Hanel A, Carlberg C. Skin colour and vitamin D: An update. Exp Dermatol. 2020;29:864–75.
S. Stewart AE, Roecklein KA, Tanner S, Kimlin MG. Possible contributions of skin pigmentation and vitamin D in a polyfactorial model of seasonal affective disorder. Medical Hypotheses. 2014: 83; 517–25.
Kollias N. The spectroscopy of human melanin pigmentation. In: Zeise L, Chedekel MR, Fitzpatrick TB, editors. Melanin: its role on human photoprotection. Overland Park, KS: Valdenmar Publishing; 1995:31–8.
Zonios G, Dimou A, Bassukas I, et al. Melanin absorption spectroscopy: new method for noninvasive skin investigation and melanoma detection. J Biomed Opt. 2008;13(1):014017.
Stein EM, Laing EM, Hall DB, et al. Serum 25-hydroxyvitamin D concentrations in girls aged 4–8 living in the southeastern United States. Am J Clin Nutr. 2006;83(1):75–81.
Hall LM, Kimlin MG, Aronov PA, et al. Vitamin D intake needed to maintain target serum 25-hydroxyvitamin D concentration in participants with low sun exposure and dark skin pigmentation is substantially higher than current recommendations. J Nutr. 2009;140(3):542–50.
Nesby-O’Dell S, Scanlon KS, Cogswell ME, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: their National health and Nutrition Examination Survey, 1988–1994. Am J Clin Nutr. 2002;76:187–92.
Harris SB, Dawson-Hughes B. Seasonal changes in plasma 25-hydroxyvitamin D concentrations of young American black and white women. Am J Clin Nutr. 1998;67:1232–6.
Kasahara AK, Singh RJ, Noymer A. Vitamin D serum seasonality in the United States. PLoS One. 2013;8(6):1–6.
Shih BB, Farrar MD, Cooke MS, et al. Fractional Sunburn Threshold UVR Doses Generate Equivalent Vitamin D and DNA Damage in Skin Types I-VI but with Epidermal DNA Damage Gradient Correlated to Skin Darkness. J Invest Dermatol. 2018;138(10):2244-52.
Fajuyigbe D, Lwin SM, Diffey BL, et al. Melanin distribution in human epidermis affords localized protection against DNA photodamage and concurs with skin cancer incidence difference in extreme phototypes. FASEB J. 2018;32(7):3700-6.
Young AR, Morgan KA, Ho TW, et al. Melanin has a Small Inhibitory Effect on Cutaneous Vitamin D Synthesis: A Comparison of Extreme Phenotypes. J Invest Dermatol. 2020;140(7):1418-26.e1.
Luxwolda MF, Kuipers RS, Kema IP, et al. Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/l. Br J Nutr. 2012;14;108(9):1557-61.
Mahmoud BH, Ruvolo E, Hexsel CL, et al. Impact of long-wavelength UVA and visible light on melanocompetent skin. J Invest Dermatol. 2010; 130: 2092-7.
Neale RE, Khan SR, Lucas RM, et al. The effect of sunscreen on vitamin D: a review. Br J Dermatol. 2019;181(5):907-15.
Passeron T, Bouillon R, Callender V, et al. Sunscreen photoprotection and vitamin D status. Br J Dermatol. 2019;181(5):916-31.
